Matthew J. Giacalone
Chief Operating Officer at Vaxiion Therapeutics, Inc.
Matthew J. Giacalone active positions
| Companies | Position | Start | End |
|---|---|---|---|
Vaxiion Therapeutics, Inc.
 Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Chief Operating Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| Corporate Officer/Principal | - | - |
Career history of Matthew J. Giacalone
Training of Matthew J. Giacalone
| San Diego State University | Doctorate Degree |
| University of California San Diego | Masters Business Admin |
Statistics
International
| United States | 4 |
Operational
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Vaxiion Therapeutics, Inc.
Vaxiion Therapeutics, Inc. BiotechnologyHealth Technology Vaxiion Therapeutics, Inc. operates as a biotechnology company. Its nanodelivery platforms are based on genetically engineered, non-living bacterial minicells that are capable of packaging, targeting and delivering a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides and imaging agents) directly to cancer cells. The company was founded by Roger Allen Sabbadini, Neil L. Berkley and William Gerhart in 2000 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Matthew J. Giacalone
- Experience
